133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study.
Saved in:
| Title: | 133 Long-term safety and efficacy of elexacaftor-tezacaftor-ivacaftor in children aged 6 and older with cystic fibrosis and at least one F508del allele: 144-week results of an open-label extension study. |
|---|---|
| Authors: | Wainwright, C. (AUTHOR), McColley, S. (AUTHOR), McNally, P. (AUTHOR), Powers, M. (AUTHOR), Ratjen, F. (AUTHOR), Rayment, J. (AUTHOR), Retsch-Bogart, G. (AUTHOR), Roesch, E. (AUTHOR), Ahluwalia, N. (AUTHOR), Chu, C. (AUTHOR), Menon, P. (AUTHOR), Weinstock, T. (AUTHOR), Davies, J. (AUTHOR) |
| Source: | Journal of Cystic Fibrosis. 2023 Supplement 3, Vol. 22, pS70-S71. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 15691993 |
|---|---|
| DOI: | 10.1016/S1569-1993(23)01066-4 |
